A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

NCT06132893 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

390

Enrollment

INDUSTRY

Sponsor class

Conditions

Focal Epilepsy

Interventions

DRUG: BHV-7000
DRUG: BHV-7000
DRUG: Placebo
DRUG: BHV-7000
DRUG: Placebo

Sponsor

Biohaven Therapeutics Ltd.